Evidence map›Paper›PMID 40080238›Full record

ArticleAdvances in therapy2025

Falls and Fractures in Patients with Geographic Atrophy: A US Claims Data Analysis.

Allen Hu, Rachel E Teneralli, Rachelle Rodriguez, Alyshah Abdul Sultan, Colleen Garey, Jessica Ackert, Rose Ong

Abstract read
In one paragraph

Article in Advances in therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Allen HuCumberland Valley Retina Consultants, Hagerstown, MD, USA.
Rachel E TeneralliJohnson & Johnson, Raritan, NJ, USA.
Rachelle RodriguezJohnson & Johnson, Raritan, NJ, USA.
Alyshah Abdul SultanJohnson & Johnson, Raritan, NJ, USA.
Colleen GareyPanalgo, Boston, MA, USA.
Jessica AckertJohnson & Johnson, Raritan, NJ, USA.
Rose OngGlobal Epidemiology, Actelion Pharmaceuticals Ltd, A Johnson & Johnson Company, Gewerbestrasse 16, 4123, Allschwil, Switzerland. cong3@its.jnj.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe increased risk of falls in elderly people represents a substantial public health burden that may be compounded by impaired visual acuity. The present study aimed to assess the independent risk of incident falls and fractures in patients with geographic atrophy (GA).

methodsThis retrospective, noninterventional, cohort study analyzed three US claims datasets (Optum's de-identified Clinformatics

resultsThe Clinformatics

conclusionGA represents an independent risk factor for falls, fractures, and higher HCRU. These data reveal the substantial public health burden of GA associated with the management of falls and fractures.

Indexed as

Accidental FallsFractures, BoneGeographic AtrophyAgedAged, 80 and overDatabases, FactualFemaleHumansInsurance Claim ReviewMaleRetrospective StudiesRisk FactorsUnited StatesAge-related macular degenerationBlindnessElderlyFallsFracturesGeographic atrophyHealth care resource utilization

Identifiers

PMID40080238
PMCPMC12006262

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.